Source:http://linkedlifedata.com/resource/pubmed/id/19713999
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-10-16
|
pubmed:abstractText |
This review considers comparisons of the off-target effects of siRNA to shRNA and their potential impact on the efficacy and toxicity of RNAi based therapeutics.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1476-5500
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
807-9
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.
|
pubmed:affiliation |
Gradalis Inc., Dallas, TX, USA.
|
pubmed:publicationType |
Journal Article,
Review
|